In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, GE HealthCare Technologies Inc’s stock clocked out at $82.52, up 0.17% from its previous closing price of $82.38. In other words, the price has increased by $0.17 from its previous closing price. On the day, 2.06 million shares were traded. GEHC stock price reached its highest trading level at $83.48 during the session, while it also had its lowest trading level at $82.25.
Ratios:
To gain a deeper understanding of GEHC’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.32 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 26.80. For the most recent quarter (mrq), Quick Ratio is recorded 0.91 and its Current Ratio is at 1.14. In the meantime, Its Debt-to-Equity ratio is 1.08 whereas as Long-Term Debt/Eq ratio is at 0.86.
Upgrades & Downgrades
In the most recent recommendation for this company, Barclays on October 13, 2025, initiated with a Equal Weight rating and assigned the stock a target price of $86.
On October 07, 2025, Citigroup Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $83.
UBS Upgraded its Sell to Neutral on May 05, 2025, while the target price for the stock was maintained at $73.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 24 ’25 when Kenneth Stacherski bought 4,585 shares for $77.00 per share.
Kenneth Stacherski bought 4,585 shares of GEHC for $361,993 on Oct 27 ’25. On Sep 22 ’25, another insider, Kenneth Stacherski, who serves as the Former Officer of the company, bought 19,524 shares for $74.46 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GEHC now has a Market Capitalization of 37675499520 and an Enterprise Value of 44555640832. As of this moment, GE’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.06, and their Forward P/E ratio for the next fiscal year is 16.67. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.33. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.85 while its Price-to-Book (P/B) ratio in mrq is 3.76. Its current Enterprise Value per Revenue stands at 2.201 whereas that against EBITDA is 12.288.
Stock Price History:
The Beta on a monthly basis for GEHC is 1.19, which has changed by 0.04397416 over the last 52 weeks, in comparison to a change of 0.13329959 over the same period for the S&P500. Over the past 52 weeks, GEHC has reached a high of $94.80, while it has fallen to a 52-week low of $57.65. The 50-Day Moving Average of the stock is 6.72%, while the 200-Day Moving Average is calculated to be 10.78%.
Shares Statistics:
It appears that GEHC traded 3.64M shares on average per day over the past three months and 3304580 shares per day over the past ten days. A total of 455.51M shares are outstanding, with a floating share count of 454.26M. Insiders hold about 0.28% of the company’s shares, while institutions hold 85.69% stake in the company. Shares short for GEHC as of 1764288000 were 11138672 with a Short Ratio of 3.06, compared to 1761868800 on 11241621. Therefore, it implies a Short% of Shares Outstanding of 11138672 and a Short% of Float of 3.2300000000000004.
Earnings Estimates
Investors are keenly observing as 14.0 analysts analyze and rate. The current performance of GE HealthCare Technologies Inc (GEHC) in the stock market.The consensus estimate for the next quarter is $1.0, with high estimates of $1.17 and low estimates of $0.91.
Analysts are recommending an EPS of between $4.59 and $4.51 for the fiscal current year, implying an average EPS of $4.55. EPS for the following year is $4.93, with 19.0 analysts recommending between $5.14 and $4.55.
Revenue Estimates
In. The current quarter, 14 analysts expect revenue to total $5.6B. It ranges from a high estimate of $5.7B to a low estimate of $5.47B. As of. The current estimate, GE HealthCare Technologies Inc’s year-ago sales were $5.32BFor the next quarter, 14 analysts are estimating revenue of $5.01B. There is a high estimate of $5.16B for the next quarter, whereas the lowest estimate is $4.93B.
A total of 20 analysts have provided revenue estimates for GEHC’s current fiscal year. The highest revenue estimate was $20.63B, while the lowest revenue estimate was $20.18B, resulting in an average revenue estimate of $20.5B. In the same quarter a year ago, actual revenue was $19.67BBased on 19 analysts’ estimates, the company’s revenue will be $21.41B in the next fiscal year. The high estimate is $21.86B and the low estimate is $21.11B.
